LIGAND PHARMACEUTICALS INC Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Grant | A | 0.00 | 1,412 | 0 | 42,695 | 41.3 K to 42.7 K (+3.42 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Grant | A | 0.00 | 1,370 | 0 | 41,283 | 39.9 K to 41.3 K (+3.43 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 111.78 | 1,284 | 143,526 | 118,081 | 119.4 K to 118.1 K (-1.08 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 3,715 | 0 | 119,365 | 115.7 K to 119.4 K (+3.21 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Payment of Exercise | F | 111.78 | 1,284 | 143,526 | 115,650 | 116.9 K to 115.7 K (-1.10 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Grant | A | 0.00 | 3,547 | 0 | 116,934 | 113.4 K to 116.9 K (+3.13 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Payment of Exercise | F | 111.78 | 3,168 | 354,119 | 126,090 | 129.3 K to 126.1 K (-2.45 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Grant | A | 0.00 | 6,390 | 0 | 129,258 | 122.9 K to 129.3 K (+5.20 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Payment of Exercise | F | 111.78 | 3,597 | 402,073 | 122,868 | 126.5 K to 122.9 K (-2.84 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Grant | A | 0.00 | 7,256 | 0 | 126,465 | 119.2 K to 126.5 K (+6.09 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Payment of Exercise | F | 111.78 | 612 | 68,409 | 10,065 | 10.7 K to 10.1 K (-5.73 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Grant | A | 0.00 | 2,230 | 0 | 10,677 | 8.4 K to 10.7 K (+26.40 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Payment of Exercise | F | 111.78 | 713 | 79,699 | 8,447 | 9.2 K to 8.4 K (-7.78 %) |
| Jan 25 2019 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Grant | A | 0.00 | 2,418 | 0 | 9,160 | 6.7 K to 9.2 K (+35.86 %) |
| Jan 14 2019 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Option Exercise | M | 74.42 | 1,931 | 143,705 | 0 | |
| Jan 14 2019 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Option Exercise | M | 56.26 | 675 | 37,976 | 2,617 | |
| Jan 14 2019 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Option Exercise | M | 21.92 | 244 | 5,348 | 0 | |
| Jan 14 2019 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Buy | M | 56.26 | 675 | 37,976 | 39,913 | 39.2 K to 39.9 K (+1.72 %) |
| Jan 14 2019 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Buy | M | 74.42 | 1,931 | 143,705 | 39,238 | 37.3 K to 39.2 K (+5.18 %) |
| Jan 14 2019 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | SVP, Gen. Counsel & ... | Buy | M | 21.92 | 244 | 5,348 | 37,307 | 37.1 K to 37.3 K (+0.66 %) |
| Jan 14 2019 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Option Exercise | M | 16.14 | 4,000 | 64,560 | 0 | |
| Jan 14 2019 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Option Exercise | M | 16.14 | 29,790 | 480,811 | 0 | |
| Jan 14 2019 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Buy | M | 16.14 | 29,790 | 480,811 | 119,209 | 89.4 K to 119.2 K (+33.32 %) |
| Jan 14 2019 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | Chief Executive Off ... | Buy | M | 16.14 | 4,000 | 64,560 | 89,419 | 85.4 K to 89.4 K (+4.68 %) |